Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      Sharecare announces second quarter 2021 financial results and operational highlights

      Updates FY 2021 revenue outlook to range of $414 million to $415 million from $408 million following the acquisition of CareLinx, a tech-enabled home health company

      Sharecare, the digital health company that helps people manage all their health in one place, today announced that it has completed its business combination with Falcon Capital Acquisition Corp. (NASDAQ: FCAC), a special purpose acquisition company. Sharecare will receive gross proceeds of over $571 million, prior to transaction expenses, including investments from funds managed by Koch Strategic Platforms and Baron Capital Group. On July 2, 2021, Sharecare will begin trading on Nasdaq as "SHCR" (PRNewsfoto/Sharecare)

      News provided by

      Sharecare

      Aug 11, 2021, 07:00 ET

      Share this article

      Share this article


      ATLANTA, Aug. 11, 2021 /PRNewswire/ -- Sharecare (Nasdaq: SHCR), the digital health company that helps people manage all their health in one place, today announced financial results for the quarter ended June 30, 2021.

      Continue Reading

       "The second quarter reflects strong financial performance across our entire business and provides a solid foundation for accelerated growth as we enter the second half of the year," said Jeff Arnold, founder, chairman, and chief executive officer of Sharecare. "Our commitment to delivering profitable, organic growth, combined with over $400 million of cash raised from our recent business combination, enables us to invest in innovation and new strategic opportunities like the acquisition of CareLinx to deliver added value to our customers while enhancing our growth."

      Sharecare updates FY 2021 revenue outlook to range of $414 million to $415 million from $408 million

      Post this

      Second Quarter 2021 Financial Results
      All comparisons, unless otherwise noted, are to the three months ended June 30, 2020.

      • Revenue of $98.5 million compared to $78.2 million, an increase of 26% and coming in at the high end of guidance
        • The acquisition of doc.ai contributed $5.0 million to revenue in the quarter
      • Net loss of $20.2 million compared to net loss of $13.7 million
        • Includes non-cash expenses of $8.9 million for the change in the fair value of warrant liabilities, anti-dilution provisions and other contingent consideration, including $2.6 million as a result of the doc.ai anti-dilution provision
      • Adjusted EBITDA of $6.6 million compared to $7.9 million, exceeding the guidance of $6.5 million, reflecting additional growth investments to support product innovation and expanded sales initiatives. Comparability with Adjusted EBITDA in Q2 2020 was impacted by temporary cost reductions as a result of furloughed employees, as well as salary and travel reductions due to COVID-19.

       Second Quarter 2021 Operational Highlights

      • Closed $50 million investment from second largest health plan in U.S. to co-develop next generation multi-payor advocacy solution as an extension to the Sharecare digital platform
      • Added new employer, government, provider, and life sciences customers
      • Launched several new government-sponsored health plans including Centene's Peach State Health Plan Medicaid line of business and Humana's CarePlus and their Medicare Advantage population
      • Won Health Net's Medicare line of business for both California and Oregon, which we believe represents an opportunity to add an estimated 800,000 new members

      Financial Outlook
      "By executing across all three of our channels – enterprise, provider, and consumer solutions – we organically grew total year-over-year revenue in the second quarter by approximately 20% while positive Adjusted EBITDA was ahead of our previous guidance," said Justin Ferrero, president and chief financial officer of Sharecare. "We've established a solid foundation and are in a strong position to invest in new opportunities to further accelerate our growth and profitability, and with 97% of our business booked, we remain confident in our full year outlook."

      As announced today, Sharecare closed the acquisition of CareLinx, a nationwide home care platform that delivers intermittent on-demand personal care services in the homes of patients, while facilitating rich data capture, population health analytics, and real-time care coordination with remote clinical teams. Positioned to serve patient needs across the entire care continuum – from personal care to clinical care in the home – this acquisition brings a human touch to Sharecare's digital solution with CareLinx's network of more than 450,000 caregivers. Read more in the official press release.

      Third Quarter 2021 Financial Guidance
      For the three months ending September 30, 2021, the Company expects:

      • Revenue in the range of $103 to $105 million, including approximately a $2 million contribution from CareLinx, representing greater than 28% growth over Q3 2020
      • Adjusted EBITDA in the range of approximately $6 to $7 million, which includes significant continued investment in sales and innovation. The Adjusted EBITDA target also includes $1 million loss in the quarter from the CareLinx acquisition.

      FY 2021 Financial Guidance
      For the twelve months ending December 31, 2021, the Company is updating its outlook to reflect the impact of the CareLinx acquisition and now expects:

      • Revenue in the range of $414 to $415 million, from approximately $408 million
      • Adjusted EBITDA in the range of $28 to $30 million, from approximately $31 million. The $2 to $3 million Adjusted EBITDA reduction is related to the CareLinx acquisition.

      Conference Call
      The Company will host a conference call to review the second quarter results today, Wednesday, August 11, 2021, at 8:00 a.m. E.T. The call can be accessed by dialing (844) 284-3435 for U.S. participants, or (914) 800-3939 for international participants, and referencing the conference ID #8885479; or via live audio webcast, available online at https://investors.sharecare.com/. A webcast replay of the call will be available for on-demand listening at the same link and will remain available for approximately 90 days.

      Non-GAAP Financial Measures
      In addition to our financial results determined in accordance with U.S. GAAP, we believe Adjusted EBITDA, a non-GAAP measure, is useful in evaluating our operating performance. We use Adjusted EBITDA to evaluate our ongoing operations and for internal planning and forecasting purposes. We believe that this non-GAAP financial measure, when taken together with the corresponding GAAP financial measure, provides meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our business, results of operations, or outlook. In particular, we believe that the use of Adjusted EBITDA is helpful to our investors as it is a metric used by management in assessing the health of our business and our operating performance. However, non-GAAP financial information is presented for supplemental informational purposes only, has limitations as an analytical tool, and should not be considered in isolation or as a substitute for financial information presented in accordance with GAAP. In addition, other companies, including companies in our industry, may calculate similarly-titled non-GAAP measures differently or may use other measures to evaluate their performance, all of which could reduce the usefulness of our non-GAAP financial measure as a tool for comparison.

      The calculation and reconciliation of historic Adjusted EBITDA to net income (loss), the most directly comparable financial measures stated in accordance with GAAP, is provided below and in the accompanying financial tables. Investors are encouraged to review the reconciliation and not to rely on any single financial measure to evaluate our business.

      We have not reconciled Adjusted EBITDA guidance to net income (loss) because we do not provide guidance for net income (loss) or for items that we do not consider indicative of our on-going performance, including, but not limited to, the impact of significant non-recurring items, as certain of these items are out of our control and/or cannot be reasonably predicted. Accordingly, a reconciliation of the Adjusted EBITDA guidance to the corresponding U.S. GAAP measure is not available without unreasonable effort.

      Adjusted EBITDA
      We calculate Adjusted EBITDA as net income (loss) adjusted to exclude (i) depreciation and amortization, (ii) interest income, (iii) interest expense, (iv) other expense (non-operating), (v) gain/loss from equity method investment, (vi) income tax (benefit) expense, (vii) share-based compensation, (viii) severance, (ix) warrant value for revenue contracts (x) common stock issues for services and (xi) transaction and closing costs. We do not view the items excluded as representative of our ongoing operations.

      About Sharecare 
      Sharecare is the leading digital health company that helps people – no matter where they are in their health journey – unify and manage all their health in one place. Our comprehensive and data-driven virtual health platform is designed to help people, providers, employers, health plans, government organizations, and communities optimize individual and population-wide well-being by driving positive behavior change. Driven by our philosophy that we are all together better, at Sharecare, we are committed to supporting each individual through the lens of their personal health and making high-quality care more accessible and affordable for everyone. To learn more, visit www.sharecare.com.

      Important Notice Regarding Forward-Looking Statements
      This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995 that are based on beliefs and assumptions and on information currently available. In some cases, you can identify forward-looking statements by the following words: "outlook," "target," "reflect," "on track," "foresees," "future," "may," "deliver," "will," "shall," "could," "would," "should," "expect," "intend," "plan," "anticipate," "believe," "estimate," "predict," "project," "potential," "continue," "ongoing" or the negative of these terms, other comparable terminology (although not all forward-looking statements contain these words), or by discussions of strategy, plans, or intentions. These statements involve risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors currently known by us and our projections of the future, about which we cannot be certain.

      Forward-looking statements in this press release include, but are not limited to, our ability to realize the benefits of recent and future acquisitions, including CareLinx, partnerships or other relationships with third parties or customers, and the statements under the caption "Financial Outlook."  We cannot assure you that the forward-looking statements in this press release will prove to be accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results. Descriptions of some of the factors that could cause actual results to defer materially from these forward-looking statements are discussed in more detail in our filings with the SEC, including the Risk Factors section of the prospectus for our business combination filed with the SEC on June 3, 2021. Furthermore, if the forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as a representation or warranty by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments will cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. You should, therefore, not rely on these forward-looking statements as representing our views as of any date subsequent to the date of this press release.

      Media Relations:
      Jen Martin Hall
      jen@sharecare.com

      Investor Relations:
      Bob East
      Bob.east@westwicke.com  
      443-450-4189

      SHARECARE, INC.
      CONSOLIDATED STATEMENTS OF OPERATIONS
      (Unaudited)
      (In thousands, except share and per share amounts)



      Three Months Ended June 30,


      Six Months Ended June 30,


      2021


      2020


      2021


      2020

      Revenue

      $

      98,459



      $

      78,228



      $

      188,068



      $

      160,156


      Costs and operating expenses:








      Costs of revenue (exclusive of depreciation and amortization below)

      48,634



      36,557



      93,028



      80,247


      Sales and marketing

      12,046



      8,364



      23,556



      17,889


      Product and technology

      15,812



      10,080



      36,266



      21,146


      General and administrative

      19,198



      22,284



      38,752



      37,680


      Depreciation and amortization

      7,167



      6,445



      13,850



      13,047


      Total costs and operating expenses

      102,857



      83,730



      205,452



      170,009


      Loss from operations

      (4,398)



      (5,502)



      (17,384)



      (9,853)


      Other income (expense):








      Interest income

      21



      16



      29



      53


      Interest expense

      (7,095)



      (7,569)



      (14,105)



      (15,423)


      Other expense

      (8,852)



      (296)



      (20,730)



      (312)


      Total other expense

      (15,926)



      (7,849)



      (34,806)



      (15,682)


      Loss before income tax (expense) benefit

      (20,324)



      (13,351)



      (52,190)



      (25,535)


      Income tax (expense) benefit

      99



      (356)



      14



      227


      Net loss

      (20,225)



      (13,707)



      (52,176)



      (25,308)


      Net (loss) income attributable to non-controlling interest in subsidiaries

      24



      (300)



      (82)



      (268)


      Net loss attributable to Sharecare, Inc.

      $

      (20,249)



      $

      (13,407)



      $

      (52,094)



      $

      (25,040)










      Net loss per share attributable to common stockholders, basic and diluted

      $

      (8.77)



      $

      (6.99)



      $

      (23.00)



      $

      (12.99)


      Weighted-average common shares outstanding, basic and diluted

      30



      9



      2,268



      2,108


      SHARECARE, INC.
      CONSOLIDATED BALANCE SHEETS
      (Unaudited)
      (In thousands, except share and per share amounts)



      As of June 30,
      2021


      As of December 31,
      2020

      Assets




      Current assets:




      Cash and cash equivalents

      $

      42,842



      $

      22,603


      Accounts receivable, net (net of allowance for doubtful accounts of $5,153 and $3,874 respectively)

      80,875



      70,540


      Other receivables

      2,527



      3,152


      Prepaid expenses

      9,558



      3,876


      Other current assets

      1,835



      1,521


      Total current assets

      137,637



      101,692


      Property and equipment, net

      4,056



      4,073


      Equity method investment

      —



      —


      Other long term assets

      19,982



      6,226


      Intangible assets, net

      120,433



      78,247


      Goodwill

      155,050



      75,736


      Total assets

      $

      437,158



      $

      265,974






      Liabilities, Redeemable Non-Controlling Interest, Redeemable Convertible Preferred Stock and Stockholders' Deficit




      Current liabilities:




      Accounts payable

      $

      30,483



      $

      19,346


      Accrued expenses and other current liabilities

      54,999



      41,058


      Deferred revenue

      30,409



      9,907


      Contract liabilities, current

      4,300



      4,045


      Debt, current

      1,157



      1,011


      Total current liabilities

      121,348



      75,367


      Contract liabilities, noncurrent

      3,983



      6,261


      Warrant liabilities

      11,120



      4,963


      Long-term debt

      166,834



      173,769


      Other long-term liabilities

      47,042



      15,070


      Total liabilities

      350,327



      275,430






      Commitments and contingencies




      Redeemable non-controlling interest

      –



      4,000


      Redeemable convertible preferred stock, $0.001 par value; 1,763,656 and 1,726,620 shares authorized; 884,033 and 877,854 shares issued and outstanding, aggregate liquidation preference of $189,213 and $186,741 as of September 30, 2020 and December 31, 2019, respectively

      242,629



      190,875






      Stockholders' deficit:




      Common stock, $0.01 par value; 5,455,000 and 5,250,000 shares authorized; 2,149,417 and 2,083,916 shares issued and outstanding as of September 30, 2020 and December 31, 2019, respectively

      2



      2


      Additional paid-in capital

      287,495



      186,279


      Accumulated other comprehensive loss

      (1,158)



      (702)


      Accumulated deficit

      (444,207)



      (392,113)


      Total Sharecare stockholders' deficit

      (157,868)



      (206,534)


      Non-controlling interest in subsidiaries

      2,070



      2,203


      Total stockholders' deficit

      (155,798)



      (204,331)


      Total liabilities, redeemable non-controlling interest, redeemable convertible preferred stock and stockholders' deficit

      $

      437,158



      $

      265,974


      SHARECARE, INC.
      RECONCILIATION OF GAAP NET LOSS TO ADJUSTED EBITDA
      (Unaudited)
      (In thousands)



      Three Months Ended June 30,


      Six Months Ended June 30,


      2021


      2020


      2021


      2020

      Net loss

      $

      (20,225)



      $

      (13,707)



      (52,176)



      $

      (25,308)


      Add:










      Depreciation and amortization

      7,167



      6,445



      13,850



      13,047


      Interest income

      (21)



      (16)



      (29)



      (53)


      Interest expense

      7,095



      7,569



      14,105



      15,423


      Other expense

      8,852



      296



      20,730



      312


      Income tax (benefit) expense

      (99)



      356



      (14)



      (227)


      Share-based compensation

      2,360



      5,166



      14,386



      5,813


      Severance

      200



      1,584



      265



      1,797


      Warrants issued with revenue contracts(a)

      (2)



      133



      38



      263


      Transaction and closing costs

      1,321



      99



      2,022



      188


      Adjusted EBITDA(b)

      $

      6,648



      $

      7,925



      13,177



      11,255






      (a)

      Represents the non-cash value of warrants issued to clients for meeting specific revenue thresholds.





      (b)

      Includes non-cash amortization associated with contract liabilities recorded in connection with acquired businesses.

      SOURCE Sharecare

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via privacy@cision.com 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.